Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E7386 in Combination With Other Anticancer Drug(s) in Subjects With Solid Tumors
NCT04008797Phase 2Active, not recruiting
- Sponsor
- Eisai Co., Ltd.
- Start
- Jul 2019
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of e7386 in solid tumor, hepatocellular carcinoma (HCC), colorectal cancer (CRC), endometrial carcinoma, sponsored by Eisai Co., Ltd.. Started Jul 2019; status: active, not recruiting.
02
Drugs
e7386
03
Conditions
solid tumorhepatocellular carcinoma (HCC)colorectal cancer (CRC)endometrial carcinoma
Beyond the preview
Go deeper on NCT04008797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04008797.